Published in AIDS Weekly, December 15th, 2003
The antibody will be directed against a novel target on Aspergillus fumigatus. This fungus can cause life-threatening infections in patients whose immune systems are compromised, for example, cancer patients receiving chemotherapy.
The target discovered by ACE BioSciences is the first in the collaboration between Genmab and ACE BioSciences that covers four commercially promising disease targets in the area of infectious diseases. Under the agreement, ACE BioSciences provides novel commercially...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.